Rapid Characterization of the Functional and Pharmacological Consequences of Cantú Syndrome KATP Channel Mutations in Intact Cells
暂无分享,去创建一个
[1] C. Nichols,et al. A Unique High‐Output Cardiac Hypertrophy Phenotype Arising From Low Systemic Vascular Resistance in Cantu Syndrome , 2022, Journal of the American Heart Association.
[2] C. Nichols,et al. Lymphedema as first clinical presentation of Cantu Syndrome: reversed phenotyping after identification of gain-of-function variant in ABCC9 , 2022, European Journal of Human Genetics.
[3] C. Nichols. Personalized Therapeutics for KATP-Dependent Pathologies. , 2022, Annual Review of Pharmacology and Toxicology.
[4] David Nedrud,et al. Determinants of trafficking, conduction, and disease within a K+ channel revealed through multiparametric deep mutational scanning , 2022, bioRxiv.
[5] C. Nichols,et al. ATP-sensitive potassium channels in zebrafish cardiac and vascular smooth muscle. , 2021, The Journal of physiology.
[6] C. Nichols,et al. Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome , 2021, Cells.
[7] John D. Russo,et al. Vascular KATP channel structural dynamics reveal regulatory mechanism by Mg-nucleotides , 2021, Proceedings of the National Academy of Sciences.
[8] C. Nichols,et al. Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome , 2020, Frontiers in Pharmacology.
[9] Hongzhen Hu,et al. Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome , 2020, JCI insight.
[10] F. Ashcroft,et al. Evaluating inositol phospholipid interactions with inward rectifier potassium channels and characterising their role in disease , 2020, bioRxiv.
[11] B. Zinselmeyer,et al. Kir6.1‐dependent KATP channels in lymphatic smooth muscle and vessel dysfunction in mice with Kir6.1 gain‐of‐function , 2020, The Journal of physiology.
[12] T. Cardozo,et al. Palmitoylation of the KATP channel Kir6.2 subunit promotes channel opening by regulating PIP2 sensitivity , 2020, Proceedings of the National Academy of Sciences.
[13] M. Itoh,et al. A novel mutation in the KCNJ8 gene encoding the Kir6.1 subunit of an ATP‐sensitive potassium channel in a Japanese patient with Cantú syndrome , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.
[14] C. Nichols,et al. The Mechanism of High-Output Cardiac Hypertrophy Arising From Potassium Channel Gain-of-Function in Cantú Syndrome , 2020, Function.
[15] C. Nichols,et al. Glibenclamide reverses cardiovascular abnormalities of Cantu Syndrome driven by KATP channel overactivity. , 2019, The Journal of clinical investigation.
[16] Kenneth A. Matreyek,et al. An improved platform for functional assessment of large protein libraries in mammalian cells , 2019, Nucleic acids research.
[17] T. Roscioli,et al. Glibenclamide treatment in a Cantú syndrome patient with a pathogenic ABCC9 gain‐of‐function variant: Initial experience , 2019, American journal of medical genetics. Part A.
[18] M. A. van der Heyden,et al. Glibenclamide and HMR1098 normalize Cantú syndrome‐associated gain‐of‐function currents , 2019, Journal of cellular and molecular medicine.
[19] A. Tinker,et al. ATP-Sensitive Potassium Channels and Their Physiological and Pathophysiological Roles. , 2018, Comprehensive Physiology.
[20] Yan Huang,et al. Cardiovascular consequences of KATP overactivity in Cantu syndrome. , 2018, JCI insight.
[21] C. Nichols,et al. Cantu syndrome–associated SUR2 (ABCC9) mutations in distinct structural domains result in KATP channel gain-of-function by differential mechanisms , 2017, The Journal of Biological Chemistry.
[22] C. Yoshioka,et al. Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM , 2017, eLife.
[23] C. Nichols,et al. Conserved functional consequences of disease-associated mutations in the slide helix of Kir6.1 and Kir6.2 subunits of the ATP-sensitive potassium channel , 2017, The Journal of Biological Chemistry.
[24] Kenneth A. Matreyek,et al. A platform for functional assessment of large variant libraries in mammalian cells , 2017, Nucleic acids research.
[25] N. Gao,et al. Structure of a Pancreatic ATP-Sensitive Potassium Channel , 2017, Cell.
[26] James Z. Chen,et al. Cryo-EM structure of the ATP-sensitive potassium channel illuminates mechanisms of assembly and gating , 2016, bioRxiv.
[27] C. Nichols,et al. The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics. , 2016, Future medicinal chemistry.
[28] W. Cui,et al. Sensitivity of KATP channels to cellular metabolic disorders and the underlying structural basis , 2016, Acta Pharmacologica Sinica.
[29] C. Nichols,et al. Differential mechanisms of Cantú syndrome–associated gain of function mutations in the ABCC9 (SUR2) subunit of the KATP channel , 2015, The Journal of general physiology.
[30] A. Wojtovich,et al. Direct Activation of β-Cell KATP Channels with a Novel Xanthine Derivative , 2014, Molecular Pharmacology.
[31] Meghan C Towne,et al. Mutation of KCNJ8 in a patient with Cantú syndrome with unique vascular abnormalities - support for the role of K(ATP) channels in this condition. , 2013, European journal of medical genetics.
[32] Anlong Li,et al. Hypotension Due to Kir6.1 Gain‐of‐Function in Vascular Smooth Muscle , 2013, Journal of the American Heart Association.
[33] K. Nanjo,et al. Clinical and functional characterization of the Pro1198Leu ABCC8 gene mutation associated with permanent neonatal diabetes mellitus , 2013, Journal of diabetes investigation.
[34] C. Weaver,et al. High-throughput screening for small-molecule modulators of inward rectifier potassium channels. , 2013, Journal of visualized experiments : JoVE.
[35] Stef van Lieshout,et al. Dominant missense mutations in ABCC9 cause Cantú syndrome , 2012, Nature Genetics.
[36] T. Flagg,et al. Muscle KATP channels: recent insights to energy sensing and myoprotection. , 2010, Physiological reviews.
[37] D. Wilson. Tissue , 2009, The Lancet.
[38] N. Cui,et al. PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[39] R. Scharfmann,et al. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. , 2006, The New England journal of medicine.
[40] F. Ashcroft,et al. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. , 2006, The New England journal of medicine.
[41] F. Cerutti,et al. Sulfonylurea treatment outweighs insulin therapy in short-term metabolic control of patients with permanent neonatal diabetes mellitus due to activating mutations of the KCNJ11 (KIR6.2) gene , 2006, Diabetologia.
[42] Colin G. Nichols,et al. KATP channels as molecular sensors of cellular metabolism , 2006, Nature.
[43] J. Haynes,et al. Protein kinase G‐induced activation of KATP channels reduces contractility of human prostate tissue , 2006, The Prostate.
[44] T. Tomoda,et al. Different glibenclamide-sensitivity of ATP-sensitive K+ currents using different patch-clamp recording methods. , 2006, European journal of pharmacology.
[45] C. Nichols,et al. ATP and sulfonylurea sensitivity of mutant ATP-sensitive K+ channels in neonatal diabetes: implications for pharmacogenomic therapy. , 2005, Diabetes.
[46] F. Ashcroft,et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. , 2004, The New England journal of medicine.
[47] W. Giles,et al. Pharmacological activation of plasma‐membrane KATP channels reduces reoxygenation‐induced Ca2+ overload in cardiac myocytes via modulation of the diastolic membrane potential , 2004, British journal of pharmacology.
[48] T. Kamishima,et al. Molecular analysis of the subtype‐selective inhibition of cloned KATP channels by PNU‐37883A , 2004, British journal of pharmacology.
[49] M. Vornanen,et al. The induction of an ATP-sensitive K+ current in cardiac myocytes of air- and water-breathing vertebrates , 2002, Pflügers Archiv.
[50] H. Huopio,et al. K(ATP) channels and insulin secretion disorders. , 2002, American journal of physiology. Endocrinology and metabolism.
[51] K. Muraki,et al. Usefulness and limitation of DiBAC4(3), a voltage-sensitive fluorescent dye, for the measurement of membrane potentials regulated by recombinant large conductance Ca2+-activated K+ channels in HEK293 cells. , 2001, Japanese journal of pharmacology.
[52] C. Nichols,et al. ATP interaction with the open state of the K(ATP) channel. , 2001, Biophysical journal.
[53] F. Ashcroft,et al. Differential response of K(ATP) channels containing SUR2A or SUR2B subunits to nucleotides and pinacidil. , 2000, Molecular pharmacology.
[54] S. Yamashita,et al. C-Terminal Tails of Sulfonylurea Receptors Control ADP-Induced Activation and Diazoxide Modulation of ATP-Sensitive K+ Channels , 2000, Circulation research.
[55] U. Panten,et al. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes , 1999, British journal of pharmacology.
[56] I. Uhde,et al. Stoichiometry of sulfonylurea-induced ATP-sensitive potassium channel closure. , 1999, Molecular pharmacology.
[57] Y. Horio,et al. ATP-Sensitive K+ channel modulator binding to sulfonylurea receptors SUR2A and SUR2B: opposite effects of MgADP. , 1999, Molecular pharmacology.
[58] J. Sullivan,et al. Characterization of the ATP-sensitive potassium channels (KATP) expressed in guinea pig bladder smooth muscle cells. , 1999, The Journal of pharmacology and experimental therapeutics.
[59] F. Ashcroft,et al. Molecular Analysis of ATP-sensitive K Channel Gating and Implications for Channel Inhibition by ATP , 1998, The Journal of general physiology.
[60] Y. Horio,et al. SUR2 subtype (A and B)‐dependent differential activation of the cloned ATP‐sensitive K+ channels by pinacidil and nicorandil , 1998, British journal of pharmacology.
[61] U. Quast,et al. Binding of KATP channel modulators in rat cardiac membranes , 1998, British journal of pharmacology.
[62] P. Rorsman,et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. , 1998, Diabetes.
[63] C. Nichols,et al. Octameric Stoichiometry of the KATP Channel Complex , 1997, The Journal of general physiology.
[64] F. Ashcroft,et al. The Interaction of nucleotides with the tolbutamide block of cloned atp‐sensitive k+ channel currents expressed in xenopus oocytes: a reinterpretation , 1997, The Journal of physiology.
[65] F. Ashcroft,et al. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor , 1997, Nature.
[66] Y. Horio,et al. Sulphonylurea receptor 2B and Kir6.1 form a sulphonylurea‐sensitive but ATP‐insensitive K+ channel. , 1997, The Journal of physiology.
[67] Y. Horio,et al. A Novel Sulfonylurea Receptor Forms with BIR (Kir6.2) a Smooth Muscle Type ATP-sensitive K+ Channel* , 1996, The Journal of Biological Chemistry.
[68] M. L. Le Beau,et al. Cloning, Tissue Expression, and Chromosomal Localization of SUR2, the Putative Drug-Binding Subunit of Cardiac, Skeletal Muscle, and Vascular KATP Channels , 1996, Diabetes.
[69] M. Permutt,et al. Adenosine Diphosphate as an Intracellular Regulator of Insulin Secretion , 1996, Science.
[70] J. K. Gibson,et al. Cardiovascular effects of the K-ATP channel blocker U-37883A and structurally related morpholinoguanidines. , 1996, Methods and Findings in Experimental and Clinical Pharmacology.
[71] J. Inazawa,et al. Reconstitution of IKATP: An Inward Rectifier Subunit Plus the Sulfonylurea Receptor , 1995, Science.
[72] P. Manley,et al. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers. , 1993, Molecular pharmacology.
[73] C F Stevens,et al. Inferences about membrane properties from electrical noise measurements. , 1972, Biophysical journal.
[74] W. Coetzee,et al. KATP Channels in the Cardiovascular System. , 2016, Physiological reviews.
[75] Daling Zhu,et al. PKA-dependent activation of the vascular smooth muscle isoform of KATP channels by vasoactive intestinal polypeptide and its effect on relaxation of the mesenteric resistance artery. , 2008, Biochimica et biophysica acta.
[76] N. Cui,et al. PKA phosphorylation of SUR 2 B subunit underscores vascular KATP channel activation by beta-adrenergic receptors , 2007 .
[77] I. So,et al. ATP-sensitive K(+) channels composed of Kir6.1 and SUR2B subunits in guinea pig gastric myocytes. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[78] J. Koster,et al. Targeted overactivity of beta cell K(ATP) channels induces profound neonatal diabetes. , 2000, Cell.
[79] C. Nichols,et al. Sulfonylurea and K(+)-channel opener sensitivity of K(ATP) channels. Functional coupling of Kir6.2 and SUR1 subunits. , 1999, The Journal of general physiology.
[80] K. Kunjilwar,et al. Toward understanding the assembly and structure of KATP channels. , 1998, Physiological reviews.